Bilirakis, Barragan, Cammack, Auchincloss, Kean & Mullin Introduce Bipartisan Bill to Permanently Protect Rare Pediatric Disease Drug Development Program -Legislation Provides Long-Term Certainty to Encourage Investment in Lifesaving Treatments for Child
September 14, 2026
September 14, 2026
WASHINGTON, Sept. 14 -- Rep. Gus M. Bilirakis, R-Florida, issued the following news release:
* * *
Bilirakis, Barragan, Cammack, Auchincloss, Kean & Mullin Introduce Bipartisan Bill to Permanently Protect Rare Pediatric Disease Drug Development Program -Legislation Provides Long-Term Certainty to Encourage Investment in Lifesaving Treatments for Childr
*
Bilirakis, Barragan, Cammack, Auchincloss, Kean & Mullin Introduce Bipartisan Bill . . .
* * *
Bilirakis, Barragan, Cammack, Auchincloss, Kean & Mullin Introduce Bipartisan Bill to Permanently Protect Rare Pediatric Disease Drug Development Program -Legislation Provides Long-Term Certainty to Encourage Investment in Lifesaving Treatments for Childr
*
Bilirakis, Barragan, Cammack, Auchincloss, Kean & Mullin Introduce Bipartisan Bill . . .